New Hope for BTC Patients: The Durvalumab + Chemo Combination in Action
Biliary tract cancer (BTC), a tough cancer that starts in the bile ducts or gallbladder, has been a serious challenge due to its poor outlook. A big trial called TOPAZ-1 showed that adding durvalumab to the standard first-line chemo (gemcitabine and cisplatin) helped patients live longer than chemo alone. This real-world study was about checking if this combo works a...